Purple Octane (Cannabis flos S-LAB): lineage from three lines and caryophyllene in the profile
Purple Octane reaches Polish pharmacies from one producer, and its origin is recorded from three breeding lines. We gather here what the data says about this strain and highlight places where it is lacking.
| Strain Card | Purple Octane |
|---|---|
| Producers | S-LAB (1 pharmacy position) |
| Medical Brand | the same as the producer |
| Alternative Names | none |
| Category by sources | hybrid with indica dominance |
| Leading Terpene | caryophyllene |
| Other Terpenes | farnesene humulene limonene linalool nerolidol terpinolene |
| Lineage | established Biscotti × Sherb Bx1 × Jealousy F2 |
| Source Consistency | one source |
- Who supplies it. Exclusively S-LAB, so there is nothing to compare versions with, and a break in supply means the absence of this strain, not another version of it.
- Profile. Caryophyllene leads, alongside farnesene, humulene, limonene, linalool, nerolidol, terpinolene. We do not provide percentage shares because sources calculate them against different totals.
- Origin. The lineage is established, with parents being Biscotti and Sherb Bx1 and Jealousy F2.
- What is missing. The profile describes one source, so there is nothing to compare it with.
What is Purple Octane and where does this strain come from?
Purple Octane is a hybrid with an indica-dominant lineage, recorded in the pedigree graph as a combination of three breeding lines: Biscotti, Sherb BX1, and Jealousy F2. The authorship of the cross is attributed to Seed Junky Genetics. It reaches Polish pharmacies as a flower from one producer and corresponds to one registered position there.
The designations with two parents indicate the breeding technique. The abbreviation BX1 indicates the first backcross generation, meaning offspring crossed back with one of the parents to stabilize traits from that side of the lineage. The symbol F2 describes the second filial generation, where traits spread wider than in the first. Thus, the pedigree record pertains to breeding material, not a specific batch of flower that reaches the pharmacy shelf.
The origin is recorded from two independent records: a seed bank maintaining strain genealogies and a Polish description of this pharmacy position. In this cluster, such a complete set is not the norm. For twenty-five out of eighty-five described cultivars, the origin remains undetermined because the breeder did not disclose it or available records provide conflicting versions. Purple Octane belongs to the better-documented part of this collection.
The assignment to a hybrid with indica dominance comes from one description and is not confirmed in the second Polish database, as it does not include this strain at all. The indica or sativa label today speaks about the plant’s structure and the history of the lines, not about what the flower contains in the package. We will break down the composition below, along with what is unknown about it.
Which producers supply Purple Octane to Polish pharmacies?
One. The strain is supplied by S-LAB, and in the comparison we are working on, it corresponds exactly to one registered position and one catalog number. There are no parallel versions to choose from, nor a second producer to compare the declared composition of the same name.
| Producer | Registered Name without Numerical Component | Declared THC Content as Range | CBD Content | Positions in Pharmacies |
|---|---|---|---|---|
| S-LAB | Cannabis flos S-LAB | 19.8-24.2% | declared as not exceeding one percent | one |
The registered name carries the declared content, which is why it stands without a numerical component in the table. The value from the label has a ten percent tolerance from the producer, so the quoted bare number returns to the text as a measurement, which it is not. The range of 19.8-24.2% is the same declaration after distributing the tolerance on both sides.
The database from which the description of this position comes marked its availability as absent at the time of data collection. This is the state of the wholesaler, not a feature of the strain: deliveries come in batches, and a single position can disappear from circulation for weeks and return without notice. We maintain a current list of what can actually be purchased in the list of strains available in Polish pharmacies, and prices are also listed there. This text describes the strain itself.
The store category hemp flower is a separate circulation: raw material sold without a prescription outside the pharmacy, which does not include pharmacy positions. Purple Octane does not belong to it. We also separately collect everything that this producer supplies to Polish pharmacies, as in this cluster, it is responsible for thirty-eight cultivars.
What does Purple Octane smell and taste like?
- farnesene farnesene
- humulene humulene
- caryophyllene caryophyllene (leading in the pharmacy list)
- limonene limonene
- linalool linalool
- nerolidol nerolidol
- terpinolene terpinolene
Descriptions come from one source, the only one that characterizes this strain: they mention a fuel-like and earthy scent, with spicy, pine, and fruity notes. These are verbal labels, not measurement results: they arise from the impression of the person describing one batch of raw material and have no scale on which they could be reproduced elsewhere.
The set of compounds provided for this position aligns with this description. At the forefront is caryophyllene, described as having a peppery and spicy note, alongside humulene associated with a hoppy bitterness and linalool with a floral profile. Further in the composition are limonene, terpinolene, nerolidol, and farnesene. Each of them is broken down in a separate text.
Descriptive scent labels do not predict effects and are not stable over time. The scent of a batch can differ after a few weeks from opening the package, as volatile compounds deplete faster than cannabinoids, and the rate of depletion depends on temperature and the seal of the container. The list of scents comes from the same base entry as the composition, so it is not an independent confirmation of it. The second Polish database for this strain does not describe it at all, making comparisons of scent descriptions between the two records impossible.
How long does it take for Purple Octane to take effect and how long does the effect last?
The pace is determined by the method of intake, not the name on the package. For Purple Octane, no one has measured the onset of effects or their duration, as no study has covered this cultivar separately. Thus, a description of the course remains dependent on whether the raw material first reaches the lungs or the stomach.
The method of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, as pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After Swallowing | |
|---|---|---|
| First Sensations | after a few minutes | from half an hour to two |
| Onset | another ten to thirty minutes | slowly, over several hours |
| Total Duration | within two to four hours | after six, sometimes eight hours |
| Typical Error | none | taking a dose after thirty minutes, which gives both doses at once |
The width of the declared range does not change anything in this rhythm. The record of 19.8-24.2% indicates how much active substance a batch may contain, not how many minutes it takes for the patient to feel anything. The method of administration and the size of the dose are determined by the attending physician; they write the prescription for the raw material from the Rpw category.
What is known and what is unknown about the effects of Purple Octane?
What is known is as much as has been demonstrated for one of the compounds in its profile, and that on animals. The strain itself does not have its own study involving patients, and the description of relaxing effects comes from the commercial database, not from scientific work. We separate these two levels below, as they often mix in descriptions.
| Study | Model and Route of Administration | What Was Demonstrated |
|---|---|---|
| Gertsch J et al., 2008 Proceedings of the National Academy of Sciences (PNAS) PMID:18574142 |
mouse (in vivo) and test tube (receptor binding, human cells) | (E)-caryophyllene selectively bound to the CB2 receptor (Ki = 155 nM) and inhibited carrageenan-induced paw swelling in wild-type mice, but not in CB2 receptor knockout mice (Cnr2-/-), indicating a CB2-dependent mechanism; the study did not include any anxiety tests. |
| Klauke AL et al., 2014 European Neuropsychopharmacology PMID:24210682 |
rodent (mouse) | Oral caryophyllene reduced late inflammatory pain in mice in the formalin test in a CB2 receptor-dependent manner, with no effect on the early phase; in a neuropathic pain model, it alleviated thermal hyperalgesia and mechanical allodynia without developing tolerance with chronic administration. |
The boundaries of both studies are recorded literally, as they are also results: In neither of the two studies was caryophyllene tested on humans or in inhaled form from flower; both works concern oral or systemic administration in mice in pain and inflammation models, not sleep or mood. On the other side stands the descriptive material: the database provides relaxing and balanced effects for this position. This is a catalog label, not a measurement result in patients.
What adverse effects have been reported after Purple Octane?
None under this name. Safety monitoring in Poland is conducted based on the registered position and batch number, so a report does not carry the name of the cultivar and cannot be assigned to it. Purple Octane has one position in pharmacies, which still does not create a separate signal to count.
Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp flower as a group of raw materials. The most commonly reported are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory, as well as anxiety increasing with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp flower in Poland do not separate them by individual products.
The assessment of whether a given pharmacy position is safe for the patient is the responsibility of the attending physician and the pharmacist dispensing the raw material. Neither the strain description nor the list of its volatile compounds can replace it.
Can a vaporization temperature table be arranged for the Purple Octane profile?
Not in the form in which such tables circulate online. Of the eleven terpenes described in this project, the public database PubChem provides boiling points along with pressure for only six, and the profile of this strain collects several positions that rank the worst in such a set.
Caryophyllene, the leading terpene in this profile, has a measurement provided along with pressure. Humulene has it only under reduced pressure: the database notes 99-100 degrees at 3 mm Hg, meaning in conditions close to vacuum. Nerolidol has a record without specified pressure, so it cannot be compared with the previous ones, and farnesene does not have a boiling point in the database at all. Thus, three out of seven positions in this profile cannot be inserted into a common table without falsifying measurement conditions.
The very idea of targeting a single terpene is based on a misunderstanding. Vaporization occurs even below the boiling point, and its rate increases exponentially with temperature; the boiling point is the temperature at which the vapor pressure equals the surrounding pressure, not a threshold for initiating vaporization. Separately, we break down the evaporation of terpenes from flower and the comparability of circulating tables. We do not suggest temperatures or equipment here: the method of administration is determined by the attending physician.
Which strains from Polish pharmacies are related to Purple Octane?
| Strain | Common Parent | Leading Terpene | Producers |
|---|---|---|---|
| Sherbert Scotti | Biscotti | caryophyllene | S-LAB |
One: Sherbert Scotti, which shares a parent named Biscotti with it. The kinship goes down one side of the pedigree, so it is closer to half-sibling status than to a pair from the same cross. Besides this name, the pedigree graph does not connect Purple Octane with any other cultivar from this set.
Sherbert Scotti comes from crossing Sunset Sherbet with Biscotti, reaches pharmacies from the same producer, and in its profile, the same terpene leads. Thus, both positions are close not only in lineage but also in what the source provides about the composition. We describe it separately.
The name component does not prove anything in either direction. Sherb from the record Sherb BX1 returns in the names King Sherb and Mystic Wonder, but the first has Blue Sherbet in its lineage, and the second has Garlic Sherbert, meaning separately named lines. Gelato 33 shares the second parent, Sunset Sherbet, with Sherbert Scotti, but nothing connects it to Purple Octane in the graph.
On the first name component side, the same problem exists. Big Purple Dragon descends from Purple Urkle, and the lineage of the strain Purps remains undetermined, so the shared word in the name does not create kinship between them nor exclude it. There is no half-sibling added by intuition in this cluster: an empty list can be a correct result, not a gap to fill.
Frequently Asked Questions about Purple Octane
Is Purple Octane an indica or sativa strain?
The record describing this position identifies it as a hybrid with indica dominance, and the second Polish strain listing does not include it at all. The label comes from one description and speaks about the history of the breeding line, not about the contents of the package.
What is the THC content in Purple Octane?
The declared content is given in the range of 19.8-24.2%, as the value from the label has a ten percent tolerance from the producer. We do not provide a single number, as it would suggest measurement precision that the declaration does not have.
Who supplies Purple Octane to Polish pharmacies?
S-LAB, as the only producer in this comparison, in one registered position. We check current availability in the list of strains available in Polish pharmacies, as a single position can disappear from the wholesaler and return after weeks.
Does Purple Octane have siblings among strains from Polish pharmacies?
It has one: Sherbert Scotti, with which it shares a parent named Biscotti. Other name similarities in this comparison do not have confirmation in the pedigree graph.
Have clinical studies been published regarding Purple Octane?
No. Available works concern a single terpene from its profile and were conducted on mice, not humans. For the cultivar itself, neither a clinical study nor a pharmacokinetic measurement has been published.
Why do you not provide percentage shares of terpenes in the profile?
Because the denominator is unknown. The sum of shares provided by the source for this strain amounts to 82 instead of one hundred, so the numbers do not add up to a whole and cannot be read as a measurement. We provide the composition as composition.
Hemp flower is a pharmaceutical raw material dispensed by a doctor’s prescription in the Rpw category. The material is informational in nature, describing the state of available data and does not replace medical advice. Editorial: ubucha.
